Skip to main content

Research · Price Index

2026 GLP-1 telehealth price index

An index of advertised semaglutide and tirzepatide pricing, membership fees, and intro-vs-ongoing pricing across U.S. telehealth providers — so you can see the market's true price structure, not just headline numbers.

Surfbound's monthly offer

Compounded semaglutide $169/monthCompounded tirzepatide $219/month

No membership fee. Provider review, medication and shipping included if prescribed.

Nothing is charged unless your medication is approved.

Surfbound Health analyzed 15 U.S. telehealth providers in its August 26, 2026 snapshot and re-checked key competitors on October 3, 2026 (see the current-source snapshot below). Surfbound's own price is flat and all-inclusive: $169/month for semaglutide and $219/month for tirzepatide, with no membership fee or required long-term prepayment. Across the August 2026 snapshot, advertised compounded semaglutide spans roughly $95–$297/month — but several of the lowest prices require a separate membership fee or an introductory rate that later rises. The counts and comparisons on this page reflect each snapshot's dataset and the evidence status labeled on each entry; secondary reports, unverified figures, and "not reverified" entries are marked accordingly.

Research briefing

For journalists & researchers

A short, quotable summary of this index. Every figure below is drawn from the dated datasets shown on this page and keeps its own denominator and observation date.

  1. 1On 2026-10-03, the current-source snapshot recorded 8 advertised offers across 5 providers — that is 8 offer rows, not 8 different providers, and not a complete census of the market.
  2. 2In the 2026-08-26 historical dataset of 15 provider entries, 8 of 15 entries recorded a separate membership or program fee on top of an advertised medication price. This describes the dated 2026-08-26 data — it is not a current market fact.
  3. 3In that same 2026-08-26 historical dataset, 4 of 15 entries explicitly recorded dose-based pricing, where the advertised monthly price rises as the dose increases. The remaining entries varied by plan or could not be confirmed.

Suggested citation: Surfbound Health. GLP-1 Telehealth Price Index, 2026-10-03 snapshot and 2026-08-26 historical dataset. https://surfbound.co/research/glp1-telehealth-price-index

Commercial disclosure: Surfbound Health is operated by Open Water Rx LLC and is included among the providers analyzed. This is publisher research with a commercial interest, not an independent clinical review. August figures are a historical snapshot, not current market facts. Preserve source dates and uncertainty when quoting; confirm current terms with each provider.

Current-source snapshot

Checked 2026-10-03

As of 2026-10-03, this Surfbound Health snapshot records 8 advertised offers across 5 providers. These are offer rows, not 8 different providers or a complete market census. It is separate from the August 26, 2026 snapshot below. Medication "from" prices are shown as medication-only where a provider bills membership separately — they are not all-in quotes. Fields marked "Not verified" were not confirmed in the checked text.

Current-source snapshot of GLP-1 telehealth pricing checked October 3, 2026, with product or formulation, medication from price, introductory and renewal membership, payment term, and evidence status per offer.
ProviderProduct / formMedication (from)Intro membershipRenewal membershipPayment termShipping / otherEvidence
Mochi Health
joinmochi.com — weight-loss medications
Compounded semaglutide (injectable)From $60/mo (medication only)$0 first month (eligible new subscribers)$79/moMonthlyNot verifiedFirst-party verified
Mochi Health
joinmochi.com — weight-loss medications
Compounded tirzepatide (injectable)From $90/mo (medication only)$0 first month (eligible new subscribers)$79/moMonthlyNot verifiedFirst-party verified
Hims
hims.com/weight-loss
Wegovy (brand-name, injectable)From $199 (medication only)$39 first month$149/mo (billed separately)Monthly; membership billed separately from medicationNot verifiedFirst-party verified
Hims
hims.com/weight-loss
Zepbound VIAL (brand-name, injectable)From $299 (medication only)$39 first month$149/mo (billed separately)Monthly; membership billed separately from medicationNot verifiedFirst-party verified
Ro
ro.co/weight-loss (FAQ)
Weight-loss membership (medication excluded)Not reverified in this snapshot (medication billed separately)$39 first month$149/mo (as low as $74/mo with annual prepay)Monthly, or annual prepay for a lower membership rateNot verifiedFirst-party verified
Henry Meds
henrymeds.com — GLP-1 weight management
GLP-1 weight management program (product/form not confirmed)From $179/mo (program; varies by plan and dose)Not verifiedNot verifiedNot verifiedShipping included if prescribed (per checked program page)First-party verified
Surfbound HealthThis site
surfbound.co/pricing
Compounded semaglutide (injectable)$169/mo (all-inclusive if prescribed)NoneSame flat priceMonth-to-month; optional prepaid supply (3-mo $495, 6-mo $960)Included when prescribedFirst-party verified
Surfbound HealthThis site
surfbound.co/pricing
Compounded tirzepatide (injectable)$219/mo (all-inclusive if prescribed)NoneSame flat priceMonth-to-month; optional prepaid supply (3-mo $645, 6-mo $1260)Included when prescribedFirst-party verified

Mochi Health — Compounded semaglutide (injectable): Medication and diagnostics are excluded from the membership fee; pricing and availability vary by state. The $139 figure ($60 medication + $79 membership) is an arithmetic sum, not a universal all-in quote. Mochi also advertises an oral semaglutide pill from $62, but its billing period was not confirmed in the checked text, so it is not presented here as a monthly price.

Mochi Health — Compounded tirzepatide (injectable): The $169 figure ($90 medication + $79 membership) is an arithmetic sum, not a universal all-in quote.

Hims — Wegovy (brand-name, injectable): Brand-name medication, not compounded; not dose-equivalent to compounded semaglutide. The source checked was hims.com only — Hers was not independently verified in this snapshot.

Hims — Zepbound VIAL (brand-name, injectable): Brand-name medication, not compounded. The source checked was hims.com only — Hers was not independently verified in this snapshot.

Ro — Weight-loss membership (medication excluded): The membership fee does not include medication. Ro's medication price was not reverified in this snapshot — this does not mean Ro does not publish a price; do not assume current medication totals.

Henry Meds — GLP-1 weight management program (product/form not confirmed): The checked Henry Meds GLP-1 weight-management page advertises a program from $179/month, with pricing varying by plan and dose, and states that provider visits, prescribed medication, supplies, and support are included. The $179 figure is not assigned here to a specific injectable, oral, or tirzepatide product, and equal doses are not assumed. Membership and prepayment terms were not confirmed in the checked text.

Surfbound Health — Compounded semaglutide (injectable): Provider review, medication, and shipping are included when prescribed. Prepaid totals are supply totals, not 90/180-day billing.

Surfbound Health — Compounded tirzepatide (injectable): Provider review, medication, and shipping are included when prescribed. Prepaid totals are supply totals, not 90/180-day billing.

Surfbound monthly payments and prepaid supplies

Monthly payments are separate from prepaid supply totals — a 3- or 6-month prepaid supply is a single supply purchase, not billing of exactly 90 or 180 days.

Compounded semaglutide

Monthly payments: 3 mo $507 · 6 mo $1,014

Prepaid supply: 3 mo $495 · 6 mo $960

Compounded tirzepatide

Monthly payments: 3 mo $657 · 6 mo $1,314

Prepaid supply: 3 mo $645 · 6 mo $1,260

Download this snapshot (JSON)

A stable, dated public JSON of the 8 offers above plus Surfbound's canonical billing totals, with source URLs and evidence status per entry. This is a dated snapshot, not a claim of always-current prices.

Download JSON

Compare the same medication, supply term, and payment schedule when evaluating a provider's full quote. Use the total-cost calculator to add up medication, membership, shipping, and dose-based charges yourself.

Data verified: 2026-08-26Last updated: 2026-10-03Published by: Surfbound Health

Key statistics — historical snapshot (August 26, 2026)

Every figure below is computed directly from the historical 15-provider dataset verified on 2026-08-26 — none is hand-entered. Competitors re-checked later (see the current-source snapshot above) are not reflected in these historical figures.

Providers evaluated

15

In its 2026-08-26 historical snapshot, Surfbound Health evaluated 15 U.S. GLP-1 telehealth providers for this price index.

Inspect dated provider rows and sources
Charge a separate membership fee

8 of 15 (53%)

In Surfbound Health's 2026-08-26 historical snapshot, 8 of 15 providers (53%) charge a separate membership or program fee on top of the medication price.

Inspect dated provider rows and sources
Use dose-based pricing

4 of 15 (27%)

In Surfbound Health's 2026-08-26 historical snapshot, 4 of 15 providers (27%) use dose-based pricing, where the monthly price rises as the dose titrates up.

Inspect dated provider rows and sources
Entries with incomplete pricing evidence

5 of 15 (33%)

In Surfbound Health's 2026-08-26 historical snapshot, 5 of 15 providers (33%) had incomplete or approximate pricing evidence for at least one of the two medications (semaglutide or tirzepatide); this does not establish that a provider never publishes a price.

Inspect dated provider rows and sources
Publish a flat, all-inclusive price

1 of 15

In Surfbound Health's 2026-08-26 historical snapshot, based on the published figures in this dataset, 1 of 15 providers publishes a single flat, all-inclusive price with no membership fee, no dose-based upcharge, and no introductory rate. Providers with UNKNOWN or unpublished figures are excluded from this count and may also offer flat pricing — this is not a claim that others do not.

Inspect dated provider rows and sources

Source types

In the 2026-08-26 historical snapshot of 15 providers, 12 were verified from first-party sources (each provider's own pricing pages and FAQs), 1 relies on secondary reporting (Found, cited from US News), and 2 use a mix of first-party and reported figures (IVIM and WeightWatchers). Source types and observation dates are labeled on each provider card.

Why no median price is reported

A median monthly price is not reported in this index because advertised prices are not single, clean numbers — they include introductory-versus-ongoing rates, dose-dependent ranges, prepaid plan discounts, and UNKNOWN or unpublished figures. Reporting a single median across such heterogeneous entries would be mathematically misleading. The index instead reports the full advertised range and the structural facts — membership fees, dose-based pricing, and pricing transparency — that determine the true monthly cost.

Disclosure: This research is published by Surfbound Health, which is included among the providers analyzed. Note: This index compiles advertised pricing and terms from the sources identified in each entry. Source types and observation dates are shown where documented. Secondary reports and unavailable information are labeled. Prices and terms can change; confirm current details with the provider. Compounded medications are not FDA-approved. This page is educational and is not medical advice — a licensed provider determines whether treatment is appropriate for you.

The 2026 price index

August 26, 2026 snapshot

Advertised monthly medication price, intro-vs-ongoing pricing, membership/program fee, and whether the price changes by dose — across every provider in this historical 15-provider dataset, with evidence status labeled per entry. Competitor pricing that changed since this snapshot is re-checked in the current-source snapshot above.

Advertised compounded semaglutide and tirzepatide prices, intro-versus-ongoing pricing, membership or program fees, and dose-based pricing across 15 U.S. GLP-1 telehealth providers, with evidence status labeled per entry.
ProviderSemaglutide (advertised)Tirzepatide (advertised)Intro → ongoingMembership / program feePrice changes by dose?
Surfbound HealthThis site
$169/mo (all doses)$219/mo (all doses)None — same price every monthNoneNo
Eden (TryEden)
$99/mo$199/mo$99 (sema) / $199 (tirz)$39 first month, then $99/mo (required)Varies
Found
Advertised "from $99/mo"; $169/mo on 12-month plan (US News Aug 2026)$239/mo on 12-month plan (US News Aug 2026)Advertised "starting at $99/month"Ongoing: Varies by plan lengthFrom $49/mo (program plan)Varies
Fridays Health
$117/mo (annual prepaid) or $249/mo (month-to-month)$198/mo (annual prepaid) or $359/mo (month-to-month)None — annual prepay lowers per-month priceOngoing: Same medication; annual prepay lower than month-to-monthNone (membership included free)Varies
Henry Meds
$297/mo (injectable); $249/mo (oral)UNKNOWN (injectable); oral ~$297–$349/moNoneNoneVaries
Hims & Hers
Base dose $149/mo, rising with dose (dose-based)UNKNOWN (compounded); brand Zepbound $1,899/mo$149/mo (base sema dose)Ongoing: Rises with dose$39 first month, then $149/mo (required)Yes
IVIM Health
$100–$125/mo (prepaid 4–6 month plans; first-party verified)$183/mo (6-month) / $225/mo (4-month) prepaid; $133/mo (12-month reported)First month membership freeOngoing: $75/mo membership thereafter$75/mo (first month free)Varies
Lavender Sky Health
Starter dose $149/mo; $95/mo with 2-month supply (dose-based)$105/mo with 2-month supply (dose-based)Starter dose $149/mo; mid dose $159/moOngoing: Varies by dose tierNone (pay per supply)Yes
LifeMD
Medication cost separate (UNKNOWN)Medication cost separate (UNKNOWN)First month program fee $39Ongoing: $149/mo program fee (or $75/mo annual)$149/mo program fee (first month $39; annual plan from $75/mo)Varies
Mochi Health
$60–$99/mo (dose-based; varies by dose, state, and pharmacy)$90–$199/mo (dose-based; varies by dose, state, and pharmacy)None — medication price varies by dose; membership $39 first monthOngoing: Same medication price; membership $79/mo$79/mo (after $39 first month)Yes
Noom Med
GLP-1Rx plan: $69 start, then $99/mo (billed quarterly; medication included)GLP-1Rx Plus plan: $149 start, then $299/mo (billed quarterly; medication included)GLP-1Rx $69 start; GLP-1Rx Plus $149 startOngoing: GLP-1Rx $99/mo; GLP-1Rx Plus $299/moIncluded in plan pricing (no separate line)Varies
OrderlyMeds
$149/mo ongoing; $74/mo intro (3-month starter, $222 upfront)$299/mo ongoing; $149/mo intro (3-month starter, $447 upfront)$74/mo semaglutide / $149/mo tirzepatide (3-month starter)Ongoing: $149/mo semaglutide / $299/mo tirzepatide ongoingNoneNo
Ro
Not offered (compounded discontinued); brand Wegovy available via membershipNot offered (compounded discontinued); brand Zepbound available via membershipNone for compounded (discontinued)Ongoing: Membership renews at plan rate$39 first month, then $74/mo (annual) or $149/moUnknown
Fifty 410
$199/mo (month-to-month); $166/mo (3-month plan); $183/mo (6-month plan)$133/mo–$166/mo (3-month programs; dose-based tiers); $198–$299/mo (month-to-month)NoneOngoing: Same as plan rateNoneYes
WeightWatchers Clinic
Compounded: uncertain (reported $129 first month, then $189/mo); brand Wegovy availableCompounded: uncertain; brand availableNone stated for compoundedOngoing: Varies by plan$25 first month, then $74/mo (12-mo) or $149/mo (month-to-month)Varies

The advertised monthly medication price and any membership/program fee are shown separately — the true monthly total is generally medication plus any required membership fee. "Intro → ongoing" shows the advertised starting price and, where stated, the ongoing/renewal rate. "Compounded" medications are not FDA-approved. This index compiles advertised pricing and terms from the sources identified in each entry; source types and observation dates are shown where documented, and secondary or reported figures are labeled. Prices and terms can change — confirm current details with the provider. Providers are listed alphabetically, with Surfbound — the publishing service — highlighted.

Download the dataset

CSV generated from the same 15 provider records shown above — including source URLs and verification dates. No separate or divergent dataset.

Advertised price vs. real monthly cost

In the August 26, 2026 historical dataset, this chart displays each provider's recorded medication price and membership fee as separate line items; it does not sum them into a single universal total, because the real total depends on dose, state, and what each program includes. It does not represent current quotes for all providers.

Advertised medication vs. membership fee

A low headline price is rarely the whole story. This shows each provider's medication "from" price and its membership as separate line items — we do not sum them into a single "effective total," because the real total depends on your dose, your state, and whether medication is even included in the membership.

SurfboundThis site$169/mo all-inclusive

MembershipNone

One flat price — medication, provider review, and shipping included when prescribed.

Mochi HealthFrom $60/mo (compounded semaglutide, dose-based)

Membership$0 first month (eligible new subscribers), then $79/mo

Medication and membership are two separate charges; the total varies by dose and state. $139 ($60 + $79) is arithmetic, not a universal all-in quote.

HimsWegovy from $199 (brand-name)

Membership$39 first month, then $149/mo

Brand-name medication (not compounded), and medication is billed separately from membership.

RoMedication price not reverified in the October 3 snapshot

Membership$39 first month, then $149/mo ($74/mo with annual prepay)

The membership does not include medication, so no all-in total is stated.

Medication "from" prices and membership terms checked 2026-10-03 from first-party sources. A starting price may not be your ongoing price. Compounded medications are not FDA-approved. Surfbound charges no membership fee.

What the data shows

Providers with a membership fee

In Surfbound Health's 2026-08-26 historical snapshot, 8 of 15 provider entries recorded a separate membership or program fee in addition to the advertised medication price. This count applies to that dated dataset, not today's entire market.

Charges a membership/program fee

Eden (TryEden)FoundHims & HersIVIM HealthLifeMDMochi HealthRoWeightWatchers Clinic

No separate membership fee

Surfbound HealthFridays HealthHenry MedsLavender Sky HealthNoom MedOrderlyMedsFifty 410

Providers with dose-based pricing

In Surfbound Health's 2026-08-26 historical snapshot of 15 providers, 4 entries explicitly recorded dose-based pricing and 2 recorded flat pricing across doses. The remaining entries varied by plan or dose tier, or could not be confirmed.

Dose-based (price rises with dose)

Hims & HersLavender Sky HealthMochi HealthFifty 410

Flat across doses

Surfbound HealthOrderlyMeds

Transparent vs. incomplete pricing

A provider's pricing is "complete" only when a clean first-party price is published for both medications and every fee is findable. In Surfbound Health's 2026-08-26 historical snapshot, 5 of 15 provider entries contained approximate ("~"), reported, or "UNKNOWN" pricing for at least one medication. That is a limitation of the recorded evidence, not proof that the provider has no published price.

Incomplete / approximate price for at least one medication

Henry MedsHims & HersIVIM HealthLifeMDWeightWatchers Clinic

Flat, all-inclusive single price (no membership, no dose upcharge, no intro jump, no unpublished fees)

Surfbound Health

In the 2026-08-26 historical dataset of 15 providers, "flat, all-inclusive" is computed from the recorded fields (no separate membership fee, dose-based pricing of "No", no introductory price that later changes, and no UNKNOWN/approximate figures). It is not a marketing ranking — it simply identifies which providers publish a single, stable, findable price. Providers with UNKNOWN or unpublished figures are excluded from this list; that is not a claim that they do not offer a flat price.

Compare headline prices and payment options

Across this index, the lowest advertised monthly price is not necessarily the lowest total cost — and neither is the same as the best overall value. Some of the cheapest headline prices come with a separate membership fee, a higher price at higher doses, or an introductory rate that later rises. Surfbound does not compete on the lowest possible headline number; it competes on overall value — one flat, all-inclusive price with no membership fee, no dose-based upcharge, no multi-month prepayment required, and provider-guided care included. That is the distinction this index is built to make clear.

Value also means getting the dose right. See our how to verify your tirzepatide dose guide for a real-world example of why the care process matters as much as the price.

Provider detail cards

Full pricing breakdown per provider — advertised price, intro and renewal pricing, membership and provider fees, shipping, dose-based pricing, prepayment, cancellation, refund, and first-, 3-, and 6-month totals — with the source, observation date, and evidence type shown on each card.

Surfbound Health

This siteCompounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Advertised semaglutide
$169/mo (all doses)
Advertised tirzepatide
$219/mo (all doses)
Intro price
None — same price every month
Renewal price
Same as advertised price
Membership fee
None
Provider / consult fee
Included
Shipping
Included
Dose-based pricing
No — flat across doses
Prepayment
None required
Cancellation
Month-to-month
Refund policy
Published refund policy (see surfbound.co/refund)
Insurance required
Not required (cash-pay)
First-month total
$169 (sema) / $219 (tirz)
3-month total
$507 (sema) / $657 (tirz)
6-month total
$1,014 (sema) / $1,314 (tirz)
Source: surfbound.co/pricing

Eden (TryEden)

Compounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Advertised semaglutide
$99/mo
Advertised tirzepatide
$199/mo
Intro price
$99 (sema) / $199 (tirz)
Renewal price
Same medication price
Membership fee
$39 first month, then $99/mo (required)
Provider / consult fee
Included in membership
Shipping
UNKNOWN
Dose-based pricing
Varies
Prepayment
None stated
Cancellation
Month-to-month
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
$138 (sema $99 + $39) / $238 (tirz $199 + $39)
3-month total
$534 (sema) / $834 (tirz)
6-month total
$1,128 (sema) / $1,728 (tirz)
Source: eden.health

Found

Compounded only (not FDA-approved)Secondary / reported

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Price figures cited from US News (Aug 2026); the provider URL is listed but does not by itself confirm the price.

Advertised semaglutide
Advertised "from $99/mo"; $169/mo on 12-month plan (US News Aug 2026)
Advertised tirzepatide
$239/mo on 12-month plan (US News Aug 2026)
Intro price
Advertised "starting at $99/month"
Renewal price
Varies by plan length
Membership fee
From $49/mo (program plan)
Provider / consult fee
Included in program
Shipping
UNKNOWN
Dose-based pricing
Varies
Prepayment
12-month plan for lowest medication price
Cancellation
Month-to-month
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
Varies
3-month total
Varies
6-month total
Varies
Source: joinfound.com; US News Aug 2026

Fridays Health

Compounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Advertised semaglutide
$117/mo (annual prepaid) or $249/mo (month-to-month)
Advertised tirzepatide
$198/mo (annual prepaid) or $359/mo (month-to-month)
Intro price
None — annual prepay lowers per-month price
Renewal price
Same medication; annual prepay lower than month-to-month
Membership fee
None (membership included free)
Provider / consult fee
Included
Shipping
Included
Dose-based pricing
Varies
Prepayment
Annual prepaid plan for lowest price
Cancellation
Month-to-month
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
$249 (month-to-month) or $117/mo effective (annual prepay)
3-month total
Varies
6-month total
Varies
Source: joinfridays.com/pricing (no separate membership fee)

Henry Meds

Compounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide (oral & injectable) · Observed 2026-08-26

Advertised semaglutide
$297/mo (injectable); $249/mo (oral)
Advertised tirzepatide
UNKNOWN (injectable); oral ~$297–$349/mo
Intro price
None
Renewal price
Same
Membership fee
None
Provider / consult fee
Included
Shipping
Included
Dose-based pricing
Varies
Prepayment
12-month prepaid lowers price
Cancellation
Month-to-month
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
$297 (injectable sema)
3-month total
$891 (injectable sema)
6-month total
$1,782 (injectable sema)
Source: henrymeds.com

Hims & Hers

Compounded semaglutide (not FDA-approved); brand Zepbound is FDA-approvedFirst-party

Compounded semaglutide (+ brand Zepbound) · Observed 2026-08-26

Advertised semaglutide
Base dose $149/mo, rising with dose (dose-based)
Advertised tirzepatide
UNKNOWN (compounded); brand Zepbound $1,899/mo
Intro price
$149/mo (base sema dose)
Renewal price
Rises with dose
Membership fee
$39 first month, then $149/mo (required)
Provider / consult fee
Included in membership
Shipping
Included
Dose-based pricing
Yes — price rises with dose
Prepayment
6-month prepaid for lowest price
Cancellation
Month-to-month
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
$188+ (sema base + $39 membership)
3-month total
Varies (dose + membership)
6-month total
Varies (dose + membership)
Source: hims.com/weight-loss

IVIM Health

Compounded only (not FDA-approved)Mixed

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Most figures are first-party; the $133/mo 12-month tirzepatide figure is reported (secondary).

Advertised semaglutide
$100–$125/mo (prepaid 4–6 month plans; first-party verified)
Advertised tirzepatide
$183/mo (6-month) / $225/mo (4-month) prepaid; $133/mo (12-month reported)
Intro price
First month membership free
Renewal price
$75/mo membership thereafter
Membership fee
$75/mo (first month free)
Provider / consult fee
Included in membership
Shipping
Included
Dose-based pricing
Varies
Prepayment
4–6 month programs; longer = lower per-month
Cancellation
Plan-based
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
Varies
3-month total
Varies
6-month total
Varies
Source: ivimhealth.com/glp1-pricing (first-party)

Lavender Sky Health

Compounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Advertised semaglutide
Starter dose $149/mo; $95/mo with 2-month supply (dose-based)
Advertised tirzepatide
$105/mo with 2-month supply (dose-based)
Intro price
Starter dose $149/mo; mid dose $159/mo
Renewal price
Varies by dose tier
Membership fee
None (pay per supply)
Provider / consult fee
Consultation/follow-up fee applies
Shipping
Included
Dose-based pricing
Yes — price rises with dose
Prepayment
Multi-month supplies (2–4 months)
Cancellation
Pay-as-you-go
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
From $95 (sema) / $105 (tirz)
3-month total
Varies
6-month total
Varies
Source: lavenderskyhealth.com/treatment-plan-pricing

LifeMD

Mixed (compounded not FDA-approved; brand is FDA-approved)First-party

Compounded + brand (insurance-dependent) · Observed 2026-08-26

Advertised semaglutide
Medication cost separate (UNKNOWN)
Advertised tirzepatide
Medication cost separate (UNKNOWN)
Intro price
First month program fee $39
Renewal price
$149/mo program fee (or $75/mo annual)
Membership fee
$149/mo program fee (first month $39; annual plan from $75/mo)
Provider / consult fee
Included in program fee
Shipping
UNKNOWN
Dose-based pricing
Varies
Prepayment
Annual plan for lower fee
Cancellation
Monthly subscription
Refund policy
UNKNOWN
Insurance required
May use insurance for brand medication
First-month total
Varies
3-month total
Varies
6-month total
Varies
Source: lifemd.com/weight-management

Mochi Health

Compounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Advertised semaglutide
$60–$99/mo (dose-based; varies by dose, state, and pharmacy)
Advertised tirzepatide
$90–$199/mo (dose-based; varies by dose, state, and pharmacy)
Intro price
None — medication price varies by dose; membership $39 first month
Renewal price
Same medication price; membership $79/mo
Membership fee
$79/mo (after $39 first month)
Provider / consult fee
Included in membership
Shipping
Included
Dose-based pricing
Yes — price rises with dose
Prepayment
None required
Cancellation
Month-to-month
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
Varies (dose-based)
3-month total
Varies (dose-based)
6-month total
Varies (dose-based)
Source: joinmochi.com (per-dose pricing update Aug 2026)

Noom Med

Compounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide (plan-tier based) · Observed 2026-08-26

Advertised semaglutide
GLP-1Rx plan: $69 start, then $99/mo (billed quarterly; medication included)
Advertised tirzepatide
GLP-1Rx Plus plan: $149 start, then $299/mo (billed quarterly; medication included)
Intro price
GLP-1Rx $69 start; GLP-1Rx Plus $149 start
Renewal price
GLP-1Rx $99/mo; GLP-1Rx Plus $299/mo
Membership fee
Included in plan pricing (no separate line)
Provider / consult fee
Included
Shipping
Included
Dose-based pricing
Varies
Prepayment
Quarterly billing
Cancellation
Subscription-based
Refund policy
UNKNOWN
Insurance required
Not required (brand options may use insurance)
First-month total
$69 (GLP-1Rx) / $149 (GLP-1Rx Plus)
3-month total
$267 (GLP-1Rx) / $747 (GLP-1Rx Plus)
6-month total
$564 (GLP-1Rx) / $1,494 (GLP-1Rx Plus)
Source: noom.com/med/pricing

OrderlyMeds

Compounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Advertised semaglutide
$149/mo ongoing; $74/mo intro (3-month starter, $222 upfront)
Advertised tirzepatide
$299/mo ongoing; $149/mo intro (3-month starter, $447 upfront)
Intro price
$74/mo semaglutide / $149/mo tirzepatide (3-month starter)
Renewal price
$149/mo semaglutide / $299/mo tirzepatide ongoing
Membership fee
None
Provider / consult fee
Included
Shipping
Included
Dose-based pricing
No — flat across doses
Prepayment
3-month starter plan for intro pricing
Cancellation
Month-to-month
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
$74 (sema starter) / $149 (tirz starter)
3-month total
$222 (sema starter) / $447 (tirz starter)
6-month total
$894 (sema ongoing) / $1,794 (tirz ongoing)
Source: orderlymeds.com/pricing

Ro

Brand-name Wegovy, Zepbound, and Foundayo are FDA-approved. Compounded semaglutide and tirzepatide were discontinued in 2026.First-party

FDA-approved brand-name GLP-1 medications only (compounded discontinued 2026) · Observed 2026-08-26

Advertised semaglutide
Not offered (compounded discontinued); brand Wegovy available via membership
Advertised tirzepatide
Not offered (compounded discontinued); brand Zepbound available via membership
Intro price
None for compounded (discontinued)
Renewal price
Membership renews at plan rate
Membership fee
$39 first month, then $74/mo (annual) or $149/mo
Provider / consult fee
Included in membership
Shipping
Included
Dose-based pricing
Unknown
Prepayment
Annual prepay lowers membership
Cancellation
Month-to-month
Refund policy
UNKNOWN
Insurance required
May use insurance for brand medication
First-month total
Varies (brand-name medication only)
3-month total
Varies
6-month total
Varies
Source: ro.co/weight-loss (verified Aug 2026)

Fifty 410

Compounded only (not FDA-approved)First-party

Compounded semaglutide + tirzepatide · Observed 2026-08-26

Advertised semaglutide
$199/mo (month-to-month); $166/mo (3-month plan); $183/mo (6-month plan)
Advertised tirzepatide
$133/mo–$166/mo (3-month programs; dose-based tiers); $198–$299/mo (month-to-month)
Intro price
None
Renewal price
Same as plan rate
Membership fee
None
Provider / consult fee
Included
Shipping
Included
Dose-based pricing
Yes — price rises with dose
Prepayment
3-month and 6-month programs for lower per-month cost
Cancellation
Pay-only-if-approved
Refund policy
UNKNOWN
Insurance required
Not required
First-month total
$199 (sema) / $133+ (tirz)
3-month total
$498 (sema) / $399 (tirz starter)
6-month total
$1,098 (sema) / varies (tirz)
Source: fifty410.com/pricing

WeightWatchers Clinic

Brand-name Wegovy, Saxenda, and tirzepatide are FDA-approved. Compounded availability unclear; some reports indicate compounded semaglutide was discontinued.Mixed

Brand-name GLP-1 medications primarily; compounded availability uncertain as of 2026 · Observed 2026-08-26

Compounded semaglutide pricing is reported ($129 first month, then $189/mo) and compounded availability is uncertain; brand pricing is first-party.

Advertised semaglutide
Compounded: uncertain (reported $129 first month, then $189/mo); brand Wegovy available
Advertised tirzepatide
Compounded: uncertain; brand available
Intro price
None stated for compounded
Renewal price
Varies by plan
Membership fee
$25 first month, then $74/mo (12-mo) or $149/mo (month-to-month)
Provider / consult fee
Included in membership
Shipping
Included
Dose-based pricing
Varies
Prepayment
6- or 12-month membership plans
Cancellation
Membership-based
Refund policy
UNKNOWN
Insurance required
May use insurance for brand medication
First-month total
Varies
3-month total
Varies
6-month total
Varies
Source: weightwatchers.com/us/weight-loss-medication (verified Aug 2026)

Hidden cost factors to check before signing up

The advertised price is rarely the total price. When comparing providers, verify each of these before you commit.

Membership fees

Many platforms require a separate monthly membership on top of the medication price (often $75–$149/mo after a discounted first month).

Provider / consult fees

Some charge a one-time consultation or recurring provider fee in addition to medication and membership.

Shipping

Most include shipping, but always confirm — and note whether cold-chain packaging or expedited delivery adds cost.

Dose-based pricing

Some providers raise the price as your dose titrates up. A "$149/mo" intro can become "$249/mo" at higher doses.

Intro-then-jump pricing

A low first-month or first-few-months price that reverts to a higher renewal rate is common. Read the renewal terms.

Prepayment & commitment

The lowest advertised rates often require 6- or 12-month prepayment. Month-to-month pricing is usually higher.

Refills & recurring charges

Confirm how refills are billed, whether auto-renewal applies, and how to pause or cancel without surprise charges.

Insurance assumptions

Cash-pay compounded pricing is separate from insurance. If you intend to use insurance, confirm coverage and your out-of-pocket before starting.

Cancellation & refunds

Check whether you can cancel month-to-month, and what (if any) refund applies to prepaid plans.

Surfbound's indexed price

This site

How Surfbound's pricing sits in this index

In the August 26, 2026 historical dataset of 15 providers, Surfbound's advertised price is flat and all-inclusive: no membership fee, no dose-based upcharge, no intro-then-jump, and no unpublished or approximate figures.

Compounded semaglutide

$169/mo

Same price at every dose. No membership fee.

Compounded tirzepatide

$219/mo

Same price at every dose. No membership fee.

What's included

Provider review, medication, and discreet shipping included when prescribed. No insurance required. Month-to-month — no multi-month prepayment.

Surfbound billing: pay monthly vs. prepaid supply

Pay monthly (month-to-month)

Semaglutide

3 mo $507 · 6 mo $1,014

Tirzepatide

3 mo $657 · 6 mo $1,314

Total paid month-to-month, no multi-month prepayment required.

Prepaid supply (optional)

Semaglutide

3 mo $495 (~$165/mo) · 6 mo $960 (~$160/mo)

Tirzepatide

3 mo $645 (~$215/mo) · 6 mo $1,260 (~$210/mo)

No 12-month prepaid GLP-1 offer exists.

In this dataset, Surfbound's $169/month semaglutide sits within the observed $95–$297/month range, and its $219/month tirzepatide sits within the observed ~$105–$299/month range — and its flat, all-inclusive price has no membership fee, no dose upcharge, and no intro rate that later rises.

What the dataset objectively supports

  • No separate membership fee — unlike 8 providers recorded in the August 26, 2026 historical dataset with a $75–$149/month membership on top of medication.
  • Flat pricing across doses — unlike the providers that raise the price as your dose titrates up.
  • No intro-then-jump — the price you see is the price you pay every month, with no teaser rate that later reverts higher.
  • no multi-month prepayment required — month-to-month, so you are not locked into a 6- or 12-month prepay to reach the advertised rate.

Some services advertise a lower starting price. Price alone does not describe the treatment experience. Surfbound is designed for patients who value straightforward month-to-month pricing, provider-guided care, responsive support, and no membership or dose-upcharge surprises.

Compounded medications available through Surfbound are not FDA-approved and are not the same as FDA-approved brand-name drugs. A licensed provider must review your case before any prescription is issued, and prescriptions are not guaranteed. Not everyone qualifies. Surfbound may not always have the lowest advertised introductory price. We believe it offers exceptional overall value for patients who care about transparent pricing, ongoing provider-guided care, responsive support, and a simple month-to-month experience.

See if Surfbound is right for you

Compare your total cost, then complete a brief online intake — a licensed provider will review your profile to determine whether GLP-1 treatment is medically appropriate for you.

No membership fee · no multi-month prepayment · Provider review required

What changed in this update?

This page was updated on 2026-10-03. The current-source snapshot was checked on 2026-10-03; the historical dataset was last verified on 2026-08-26.

October 3, 2026 — current-source snapshot

  • Mochi Health re-checked: compounded semaglutide from $60 and tirzepatide from $90 (medication only), with an eligible-new-subscriber $0 first month, then $79/month. Medication and diagnostics are excluded from the membership; pricing varies by state. The $139/$169 figures are arithmetic sums, not universal all-in quotes.
  • Hims re-checked (hims.com only; Hers not independently verified in this snapshot): now advertises brand-name Wegovy from $199 and Zepbound VIAL from $299 (medication only), with a $39 first-month membership rising to $149/month billed separately. These are brand-name medications, not compounded.
  • Ro re-checked: membership $39 first month, $149 ongoing monthly, as low as $74/month with annual prepay; medication is excluded from the membership, and Ro's medication price was not reverified in this snapshot.
  • Henry Meds re-checked: its GLP-1 weight-management page now advertises a program from $179/month (varying by plan and dose, with provider visits, prescribed medication, supplies and support included). The figure is not assigned to a specific product or form, and equal doses are not assumed; membership and prepayment terms were not confirmed.

August 26, 2026 — historical snapshot

  • Ro no longer offers compounded semaglutide or tirzepatide — it discontinued compounded GLP-1 medications in 2026 and now lists FDA-approved brand-name medications only. It is marked "dose-based: N/A" in this index.
  • Compounded semaglutide availability at WeightWatchers is now uncertain (some reports indicate it was discontinued), and its compounded tirzepatide availability is also uncertain; brand-name options remain available.
  • Mochi Health updated its per-dose pricing (August 2026) and now advertises a dose-based range — $60–$99/month for semaglutide and $90–$199/month for tirzepatide — that varies by dose, state, and pharmacy.
  • Found price figures are now cited from US News (August 2026) rather than a first-party pricing page, and are labeled "Secondary / reported" on its card.

Methodology & sources

Observation date: 2026-08-26

Sample size

15 U.S. telehealth providers

Observation date

2026-08-26

Source status

Labeled per entry. 12 of 15 providers were verified from first-party sources (their own pricing pages and FAQs); 1 relies on secondary reporting (Found, via US News); and 2 use a mix (IVIM and WeightWatchers). Secondary or reported figures are labeled on their entry cards.

UNKNOWN values

Where a first-party figure could not be confirmed, the field is marked "UNKNOWN" — never estimated.

How prices were collected & compared

  1. 1For each provider, we recorded the advertised cash-pay monthly price for compounded semaglutide and compounded tirzepatide from the provider’s own pricing page or FAQ (first-party). Where a provider did not publish a first-party figure, we used a documented secondary source and labeled it as such.
  2. 2We recorded membership and program fees, provider/consult fees, and shipping separately from the medication price, so the true monthly cost is visible rather than folded into a single headline number.
  3. 3We recorded whether the advertised price is introductory (reverting to a higher ongoing rate), whether it changes by dose, and any prepayment or commitment required to reach the advertised rate.
  4. 4Where a figure could not be confirmed, the field is marked UNKNOWN — it is never estimated or backfilled.
  5. 5Surfbound’s prices are read live from its published pricing page (the same centralized source used across this site); competitor figures come from the source labeled on each entry card.
  6. 6Simple arithmetic totals (first-month, 3-month, and 6-month) add the advertised medication price plus any required membership fee where both are published.

Data fields compared

Advertised semaglutide priceAdvertised tirzepatide priceMembership / program feeProvider feeShippingIntro vs. ongoing priceDose-based pricingPrepaymentCancellationRefund policyInsurance

This index compares the advertised cash-pay price of compounded GLP-1 telehealth treatment across 15 U.S. providers. This index compiles advertised pricing and terms from the sources identified in each entry. Source types and observation dates are shown where documented. Secondary reports and unavailable information are labeled. Prices and terms can change; confirm current details with the provider. Where a first-party figure could not be confirmed, the field is marked UNKNOWN — or shown as "reported" only when a secondary source is all that was available — rather than estimated.

Providers are listed alphabetically, with Surfbound — the publishing service — highlighted. Surfbound is our recommended choice for patients who prioritize overall value, transparent pricing, provider-guided care, and a simple month-to-month experience.

Surfbound's pricing is read live from its published pricing page (the same centralized source used across this site). Competitor figures are pulled from the sources labeled on each entry — primarily each provider's own website, with secondary or reported figures labeled. The objective summaries on this page (membership fees, dose-based pricing, transparent vs. incomplete) are computed directly from the labeled dataset — not asserted by hand.

Three limitations apply to every figure shown here:

  • Advertised prices are a snapshot — they change frequently, and a provider may run promotions or vary pricing by state. Always confirm on the provider’s own site before deciding.
  • Compounded medications are not FDA-approved and differ from FDA-approved brand-name drugs (Wegovy, Zepbound, Ozempic, Mounjaro). This index focuses on compounded cash-pay pricing unless a brand price is explicitly stated.
  • Simple arithmetic totals (medication plus membership) do not include taxes, dose-based upcharges a provider may apply, or state-by-state availability differences.

Compounded medications available through Surfbound are not FDA-approved and are not the same as FDA-approved brand-name drugs. A licensed provider must review your case before any prescription is issued, and prescriptions are not guaranteed. See Surfbound's safety information and pricing page for full details.

How to cite the historical August dataset

This index is original research published by Surfbound Health. You may reference or reproduce its figures with attribution, including in editorial coverage, comparison write-ups, and machine-generated summaries. No DOI or academic credential is claimed — the dataset is a web publication maintained by Surfbound Health.

Suggested citations

APA

Surfbound Health. (2026). 2026 GLP-1 telehealth price index [Data set]. Retrieved October 3, 2026, from https://surfbound.co/research/glp1-telehealth-price-index

Plain text

Surfbound Health, "2026 GLP-1 Telehealth Price Index," data verified August 26, 2026, last updated October 3, 2026. https://surfbound.co/research/glp1-telehealth-price-index

Attribution fields

Publisher / creator
Surfbound Health
Title
2026 GLP-1 Telehealth Price Index
Data verified
2026-08-26
Last updated
2026-10-03
Canonical URL
https://surfbound.co/research/glp1-telehealth-price-index
Format
Web page + downloadable CSV

When citing a specific figure

The historical membership, dose-pricing and evidence-completeness counts use the 2026-08-26 dataset of 15 providers, with a source type and observation date. When quoting a specific number (for example, the count of providers that charge a separate membership fee), attribute it to "Surfbound Health's 2026 GLP-1 telehealth price index" and note the data-verified date of 2026-08-26. Advertised prices are a point-in-time snapshot and can change — confirm current figures with each provider before republishing. The separate October 3, 2026 download contains 8 offers across 5 providers; cite that snapshot and its own observation date for those offers. A page update date does not mean every source was rechecked.

This dataset is distinct from third-party sources cited within it (for example, Found's figures attributed to US News). Those third-party citations remain attributed to their original publishers and are not presented as Surfbound's own research.

Frequently asked questions

It is Surfbound’s reference index of advertised cash-pay pricing for compounded semaglutide and tirzepatide across 15 U.S. telehealth providers, compiled from the sources labeled in each entry as of August 26, 2026 (the historical snapshot) plus a current-source snapshot re-checked on October 3, 2026. The index separates the advertised medication price from membership fees, provider fees, dose-based pricing, and intro-versus-ongoing pricing so you can compare the market’s true price structure rather than a single headline number.

Advertised compounded semaglutide pricing in the August 2026 snapshot ranged from about $95–$99/month at the low end (Lavender Sky, Eden) up to roughly $297/month as recorded in that snapshot, with several providers in between. Several of the lowest headline prices come with a separate membership fee or an introductory rate that later rises. Surfbound’s semaglutide is $169/month, flat at every dose, with no membership fee and provider review, medication, and shipping included when prescribed. See the current-source snapshot above for the latest competitor figures.

Advertised compounded tirzepatide pricing is harder to pin down across providers — several do not publish a clean first-party tirzepatide price (marked UNKNOWN in this index), while others list a "from" or approximate figure. Among providers that publish one in the August 2026 snapshot, prices span roughly $105–$299/month. Surfbound’s tirzepatide is $219/month, flat at every dose, with no membership fee and provider review, medication, and shipping included when prescribed.

8 of the 15 providers in Surfbound Health's August 26, 2026 historical snapshot recorded a separate membership or program fee on top of the medication price: Eden, Found, Hims & Hers, IVIM Health, LifeMD, Mochi Health, Ro, and WeightWatchers Clinic. The recorded fee terms can differ from current quotes. In that same historical snapshot, Surfbound Health, Fridays Health, Henry Meds, Lavender Sky Health, Noom Med, OrderlyMeds, and Fifty 410 were recorded without a separate membership fee (some recorded per-supply or consult fees instead).

Many providers advertise a low first-month or first-few-months price that reverts to a higher ongoing rate. Examples in the August 2026 snapshot include OrderlyMeds (semaglutide $74/month for the first three months, then $149/month) and WeightWatchers ($129 first month, then $189/month). Surfbound does not use introductory pricing — the price you see is the same every month.

Some providers increase the monthly price as your dose titrates up, so a low starting price can climb significantly at a maintenance dose. 4 providers in the August 2026 snapshot explicitly use dose-based pricing: Hims & Hers, Lavender Sky Health, Mochi Health, and Fifty 410. Surfbound charges the same flat price at every dose — $169/month for semaglutide and $219/month for tirzepatide.

Transparency here is measured by objective criteria: a single flat all-inclusive price, no separate membership fee, no dose-based upcharge, no intro-then-jump, and no unpublished or approximate figures. In the August 26, 2026 historical dataset, Surfbound’s own advertised offer meets all of these criteria. Several competitors publish clean medication prices but add a membership fee or dose-based pricing; other entries had unconfirmed or approximate first-party pricing for one or both medications. This is a dataset observation, not a ranking — some competitors’ figures are approximate, reported, or UNKNOWN.

"Best overall value" depends on your priorities — whether you value flat predictable pricing, insurance coverage, or a specific brand-name medication. By the objective criteria compared in this index (a single flat all-inclusive price, no separate membership fee, no dose-based upcharge, and no intro-then-jump), Surfbound’s own offer meets all of them: compounded semaglutide at $169/month and tirzepatide at $219/month, flat at every dose with provider review, medication, and shipping included when prescribed. Some competitors advertise a lower starting price that later rises or adds a separate membership fee, so compare total recurring cost rather than a headline number.

There is no single "cheapest" option, because a low headline price can hide a membership fee, dose-based increases, or an introductory rate that later rises. This index reports each provider’s advertised medication price and its membership separately rather than ranking a universal winner. For a flat, all-inclusive compounded price with no membership fee, Surfbound publishes $169/month for semaglutide and $219/month for tirzepatide at every dose. Always compare medication plus membership plus shipping plus any dose-based changes before deciding.

No. Compounded semaglutide and tirzepatide are not FDA-approved; they are prepared by licensed compounding pharmacies. FDA-approved brand-name versions (Wegovy, Zepbound, Ozempic, Mounjaro) are different products. A licensed provider must determine whether treatment is medically appropriate for you, and prescriptions are not guaranteed.

Affordability depends on total recurring cost, not just an advertised introductory price. Membership fees, dose increases, shipping, consultation fees, and prepayment can all raise the true monthly cost. Surfbound prices tirzepatide at a flat $219/month at every dose, with no membership fee and provider review, medication, and shipping included when prescribed. While some competitors advertise a lower introductory price, Surfbound is our recommendation for overall value because its pricing is flat and straightforward, with no membership fee or dose-based upcharge.